John C Reed
Evp, Innovative Medicine, R&D at Johnson & Johnson (JNJ)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $17.3M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Feb 18SEC | JNJJohnson & Johnson | Sell | 21,721 | $243.00 | $5.3M | +4.1% |
| Feb 18SEC | JNJJohnson & Johnson | Sell | 29,927 | $243.00 | $7.3M | +4.1% |
| Feb 18SEC | JNJJohnson & Johnson | Sell | 2,283 | $243.00 | $555K | +4.1% |
| Oct 20SEC | JNJJohnson & Johnson | Sell | 21,721 | $192.71 | $4.2M | +31.3% |
- Sell
Evp, Innovative Medicine, R&D John C Reed sold $5.3M of JNJ at $243.00 — cuts the stake by 63%.
- Sell
Evp, Innovative Medicine, R&D John C Reed sold $7.3M of JNJ at $243.00 — cuts the stake by 70%.
- Sell
Evp, Innovative Medicine, R&D John C Reed sold $4.2M of JNJ at $192.71 — cuts the stake by 67%.